
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
Manager, Regulatory Delivery Excellence, China Regulatory Affairs
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.
Purpose:
The Associate/Manager, Regulatory Delivery Excellence (RDE), China Regulatory Affairs is responsible for activities related to the regulatory registration management processes and submission preparation support. The scope of the work includes the clinical trial permit (CTP) applications through withdrawal of the marketing applications.
Primary Responsibilities:
This job description is intended to provide a general overview of the job requirements at the time it was prepared. The job requirements of any position may change over time and may include additional responsibilities not specifically described in the job description. Consult with your supervision regarding your actual job responsibilities and any related duties that may be required for the position.
- Manage the registration process by providing expertise in submission regulations, guidance and technical contents. Ensure compliance with all applicable regulations and internal quality systems.
- Develop submission plans for assigned projects:
- Partner with Regulatory TA & CMC team members, vendors and other contributing functions to develop submission plans, including dossier lists, timelines etc.
- Collaborate with the related functions to ensure effective execution of the submission plan.
- Manage RIM-related activities and collaborate with GRA RD&E team to support the submission plan
- Escalate issues that may impact submissions and timelines.
- Support regulatory TA & CMC teams on submission related activities:
- Arrange translations and manage the quality checks of translated materials.
- contribute local Module 1 documents to RIM content plans for new MAAs, Line extensions and new indications
- Author administrative documents based on guidance from Regulatory scientists
- Perform document formatting and manage the quality checks
- Compile submission dossiers according to the submission plan
- Execute QC testing-related activities, including material ordering, contract execution, and vendor communication etc.
- Serve as the Subject Matter Expert (SME) for regulatory business processes and how those are executed in the Veeva Vault RIM system to ensure consistency of process execution and data.
- Input and maintain data in China/global IT system, e.g. RIM, China submission archive and maintenance platform, etc.Develop collaborative relationships with personnel in the related functions (e.g. CRP, SC, GPS, Stats, CDTL, CSM, GRA RD&E,etc.) to effectively execute the registration plan.
- Leverage internal and external forums to continue to develop and share regulatory, drug development, and therapeutic expertise.
Minimum Qualification Requirements:
- At least bachelor’s degree in pharmaceutical or chemical/biopharmaceutical sciences
- At least 2 year experience in drug regulatory affairs or drug development for manager (P2)
- Preferable to experience in leading pharmaceutical company
- Good skill on English writing, speaking and listening
- Good skill on computer operation
- Self-motivated
Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.
Lilly does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.
#We Are Lilly
閲覧数
1
応募クリック
0
Mock Apply
0
スクラップ
0
類似の求人

Manager - Quality
Maersk · China, Shanghai, Shanghai, 201103

Assistant Category Manager – Safety and Nautical
Maersk · China, Shanghai, Shanghai, 200003
Quality Manager
Nextracker · China, Shenzhen
General Demand Planning Manager
Nextracker · China, Shanghai

Supplier Operations Program Manager
NVIDIA · China, Shenzhen
Eli Lillyについて

Eli Lilly
PublicEli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
10,001+
従業員数
China
本社所在地
$588B
企業価値
レビュー
10件のレビュー
3.8
10件のレビュー
ワークライフバランス
3.2
報酬
4.1
企業文化
3.7
キャリア
2.8
経営陣
3.9
72%
知人への推奨率
良い点
Excellent compensation and benefits
Supportive management and leadership
Flexible work arrangements
改善点
Limited career advancement opportunities
High stress and demanding workload
Fast-paced and high-pressure environment
給与レンジ
56件のデータ
Mid/L4
Senior/L5
Mid/L4 · ADVISOR - BRD ANALYTICAL DEVELOPMENT
2件のレポート
$188,000
年収総額
基本給
$145,411
ストック
-
ボーナス
-
$188,000
$188,000
面接レビュー
レビュー2件
難易度
2.5
/ 5
期間
14-28週間
内定率
100%
体験
ポジティブ 50%
普通 50%
ネガティブ 0%
面接プロセス
1
Application Review
2
HR Screen
3
Phone/Video Interview
4
Hiring Manager Interview
5
Final Interview/Panel
6
Offer
よくある質問
Behavioral/STAR
Past Experience
Culture Fit
Industry Knowledge
Technical Knowledge
最新情報
Eli Lilly: A Heavyweight Battle Isn't Won In Round 1 (NYSE:LLY) - Seeking Alpha
Seeking Alpha
News
·
1w ago
Why Eli Lilly (LLY) Shares Are Trading Lower Today - StockStory
StockStory
News
·
1w ago
A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B - statnews.com
statnews.com
News
·
1w ago
Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters
Reuters
News
·
1w ago